Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Editorial

Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination?

Byung-Cheol Song

Clin Mol Hepatol. 2016;22(4):439-442. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0108

View: 7840 Download: 111 Web of Science: 1 Crossref: 1

Review

New perspectives of biomarkers for the management of chronic hepatitis B

Chih-Lin Lin, Jia-Horng Kao

Clin Mol Hepatol. 2016;22(4):423-431. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0069

View: 13361 Download: 547 Web of Science: 49 Crossref: 48

Original Article

Comparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment

Hong Joo Kim, Soo Kyung Park, Hyo Joon Yang, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim, Kyu Yong Choi

Clin Mol Hepatol. 2016;22(3):350-358. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0019

View: 9350 Download: 139 Web of Science: 1 Crossref: 1

Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B

Jaemin Lee, Sun Hong Yoo, Won Sohn, Hyung Woo Kim, Yong Sun Choi, Jung Ho Won, Jin Young Heo, Sang Jong Park, Young Min Park

Clin Mol Hepatol. 2016;22(3):339-349. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0021

View: 12081 Download: 165 Web of Science: 19 Crossref: 19

Editorial

Does obesity increase the risk of hepatocellular carcinoma in chronic hepatitis B patients?

Byoung Kuk Jang

Clin Mol Hepatol. 2016;22(3):336-338. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0104

View: 8337 Download: 118 Web of Science: 2 Crossref: 1

Case Report

Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases

Hyeki Cho, Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Kook-Hwan Oh, Kyoungbun Lee, Syifa Mustika, Jung-Hwan Yoon, Yoon Jun Kim

Clin Mol Hepatol. 2016;22(2):286-291. Published online June 25, 2016

DOI: https://doi.org/10.3350/cmh.2015.0066

View: 10711 Download: 175 Web of Science: 11 Crossref: 13

Original Article

The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy

Jeong Han Kim, Sung Hyun Ahn, Soon Young Ko, Won Hyeok Choe, Kyun-Hwan Kim, So Young Kwon

Clin Mol Hepatol. 2016;22(2):241-249. Published online June 15, 2016

DOI: https://doi.org/10.3350/cmh.2015.0053

View: 10167 Download: 138 Web of Science: 4 Crossref: 4

Editorial

Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?

Hyung Joon Yim

Clin Mol Hepatol. 2016;22(2):238-240. Published online June 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0103

View: 8595 Download: 96 Web of Science: 1 Crossref: 1

Original Article

Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B

Chan Ho Park, Seok Won Jung, Jung Woo Shin, Mi Ae Bae, Yoon Im Lee, Yong Tae Park, Hwa Sik Chung, Neung Hwa Park

Clin Mol Hepatol. 2016;22(1):152-159. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.152

View: 9694 Download: 94

Review

KASL clinical practice guidelines: management of chronic hepatitis B

Clin Mol Hepatol. 2016;22(1):18-75. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.18

View: 25276 Download: 262 Web of Science: 155 Crossref: 136

Original Article

Erectile dysfunction in patients with liver disease related to chronic hepatitis B

Min Kim, Seul Young Kim, Woo Sun Rou, Se Woong Hwang, Byung Seok Lee

Clin Mol Hepatol. 2015;21(4):352-357. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.352

View: 9721 Download: 129 Web of Science: 27 Crossref: 26

Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy

Jung Gil Park, Soo Young Park

Clin Mol Hepatol. 2015;21(3):242-248. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.242

View: 8456 Download: 85 Web of Science: 5 Crossref: 3

Static and dynamic prognostic factors for hepatitis-B-related acute-on-chronic liver failure

Jung Min Ha, Won Sohn, Ju Yeon Cho, Jeung Hui Pyo, Kyu Choi, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Chul Koh, Seung Woon Paik, Byung Chul Yoo, Yong-Han Paik

Clin Mol Hepatol. 2015;21(3):232-241. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.232

View: 8238 Download: 92 Web of Science: 8 Crossref: 8

Impact of prior lamivudine use on the antiviral efficacy and development of resistance to entecavir in chronic hepatitis B patients

Joo An Hwang, Kee Bum Kim, Min Jae Yang, Sun Gyo Lim, Jae Chul Hwang, Jae Youn Cheong, Sung Won Cho, Soon Sun Kim

Clin Mol Hepatol. 2015;21(2):131-140. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.131

View: 8250 Download: 84 Web of Science: 2 Crossref: 2

Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients

Sang Kyung Jung, Kyung-Ah Kim, So Young Ha, Hyun Kyo Lee, Young Doo Kim, Bu Hyun Lee, Woo Hyun Paik, Jong Wook Kim, Won Ki Bae, Nam-Hoon Kim, June Sung Lee, Yoon Jung Jwa

Clin Mol Hepatol. 2015;21(1):41-48. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.41

View: 8799 Download: 84 Web of Science: 14 Crossref: 11

The factors associated with longitudinal changes in liver stiffness in patients with chronic hepatitis B

In Ku Yo, Oh Sang Kwon, Jin Woong Park, Jong Joon Lee, Jung Hyun Lee, In Sik Won, Sun Young Na, Pil Kyu Jang, Pyung Hwa Park, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim

Clin Mol Hepatol. 2015;21(1):32-40. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.32

View: 9744 Download: 88 Web of Science: 13 Crossref: 12

Efficacy of prolonged entecavir monotherapy in treatment-naïve chronic hepatitis B patients exhibiting a partial virologic response to entecavir

Han Na Choi, Jeong Eun Song, Hyeon Chul Lee, Hyeong Ho Jo, Chang Hyeong Lee, Byung Seok Kim

Clin Mol Hepatol. 2015;21(1):24-31. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.24

View: 9076 Download: 110 Web of Science: 14 Crossref: 14

Review

Personalized treatment of hepatitis B

Anna S. Lok

Clin Mol Hepatol. 2015;21(1):1-6. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.1

View: 8876 Download: 140 Web of Science: 19 Crossref: 19

Original Article

Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?

Byung-Cheol Song, Yoo-Kyung Cho, Hyeyoung Jwa, Eun Kwang Choi, Heung Up Kim, Hyun Joo Song, Soo-Young Na, Sun-Jin Boo, Seung Uk Jeong

Clin Mol Hepatol. 2014;20(4):355-360. Published online December 24, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.4.355 Correction in: Clin Mol Hepatol 2015;21(1):104

View: 8289 Download: 76 Web of Science: 6 Crossref: 7

Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B

Hyo Jung Cho, Soon Sun Kim, Seun Joo Ahn, Joo Han Park, Dong Joon Kim, Young Bae Kim, Sung Won Cho, Jae Youn Cheong

Clin Mol Hepatol. 2014;20(4):347-354. Published online December 24, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.4.347

View: 8767 Download: 127 Web of Science: 16 Crossref: 15

Long-term outcomes of two rescue therapies in lamivudine-refractory patients with chronic hepatitis B: combined lamivudine and adefovir, and 1-mg entecavir

EunYoung Ze, Eun Kyung Baek, Jong Jin Lee, Han Wook Chung, Dae Geon Ahn, Hwan Jun Cho, Jae Cheol Kwon, Hyung Joon Kim, HyunWoong Lee

Clin Mol Hepatol. 2014;20(3):267-273. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.267

View: 8187 Download: 71 Web of Science: 4 Crossref: 5

Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naïve chronic hepatitis B patients in Korea: data from the clinical practice setting in a single-center cohort

Sung Soo Ahn, Young Eun Chon, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jun Yong Park

Clin Mol Hepatol. 2014;20(3):261-266. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.261

View: 9579 Download: 78 Web of Science: 13 Crossref: 10

HBsAg level and clinical course in patients with chronic hepatitis B treated with nucleoside analogue: five years of follow-up data

Jeong Han Kim, Yun Jung Choi, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon

Clin Mol Hepatol. 2013;19(4):409-416. Published online December 28, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.4.409

View: 6521 Download: 61 Crossref: 6

Durability after discontinuation of nucleos(t)ide therapy in chronic HBeAg negative hepatitis patients

Young Jip Kim, Kichan Kim, Sun Hyuk Hwang, Soon Sun Kim, Dami Lee, Jae Youn Cheong, Sung Won Cho

Clin Mol Hepatol. 2013;19(3):300-304. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.300

View: 7724 Download: 82 Crossref: 27

Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients

Jeong Han Kim, Soon Young Ko, Won Hyeok Choe, So Young Kwon, Chang Hong Lee

Clin Mol Hepatol. 2013;19(3):273-279. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.273

View: 6660 Download: 40 Crossref: 1

Review

Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade

Hyung Joon Yim, Seong Gyu Hwang

Clin Mol Hepatol. 2013;19(3):195-209. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.195

View: 11917 Download: 71 Crossref: 24

KASL Clinical Practice Guidelines: Management of chronic hepatitis B

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2012;18(2):109-162. Published online June 26, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.2.109

View: 15727 Download: 109 Crossref: 120

Original Article

Virologic response is not durable after adefovir discontinuation in lamivudine-resistant chronic hepatitis B patients

Young Kul Jung, Jong Eun Yeon, Kwang Gyun Lee, Eun Seok Jung, Jeong Han Kim, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Sun Ho Um, Ho Sang Ryu, Kwan Soo Byun

Clin Mol Hepatol. 2011;17(4):261-267. Published online December 26, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.4.261

View: 6711 Download: 49 Crossref: 10

Prevalence of IgG anti-HAV in patients with chronic hepatitis B and in the general healthy population in Korea

Sang Ho Lee, Hyoung Su Kim, Kwon Oh Park, Jong Won Park, Seung Yeon Chun, Seung Jin Lim, Hyun Jung Cho, Sung Jun Kim, Hye Won Park, Han Kook Moon, Woon Geon Shin, Kyung Ho Kim, Myoung Kuk Jang, Jin Heon Lee, Hak Yang Kim

Clin Mol Hepatol. 2010;16(4):362-368. Published online December 31, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.4.362

View: 7604 Download: 40 Crossref: 8

The Korean Journal of Hepatology Elsewhere

Growing attention to an old marker, hepatitis B surface antigen, in the natural history of chronic hepatitis B

Jeong Won Jang

Clin Mol Hepatol. 2010;16(3):342-346. Published online September 30, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.3.342

View: 6169 Download: 59 Crossref: 1

1 | 2 | 3 | 4 |

Viewed By 4871	MAFLD: How is it different from NAFLD?
Viewed By 4819	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4661	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4398	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4340	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 214	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 155	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 133	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 117	MAFLD: How is it different from NAFLD?
Cited By 94	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search